Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:0874)
Hong Kong
· Delayed Price · Currency is HKD 16.96
+0.42 (2.54%)
Apr 30, 2025, 4:08 PM HKT
HKG:0874 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 74,306 | 74,779 | 75,275 | 70,550 | 68,758 | 61,450 | Upgrade
|
| Other Revenue | 214.3 | 214.3 | 240.53 | 237.96 | 256.1 | 223.35 | Upgrade
|
| Revenue | 74,520 | 74,993 | 75,515 | 70,788 | 69,014 | 61,674 | Upgrade
|
| Revenue Growth (YoY) | -3.01% | -0.69% | 6.68% | 2.57% | 11.90% | -5.05% | Upgrade
|
| Cost of Revenue | 62,514 | 62,518 | 61,373 | 57,548 | 55,825 | 51,282 | Upgrade
|
| Gross Profit | 12,006 | 12,475 | 14,143 | 13,240 | 13,189 | 10,392 | Upgrade
|
| Selling, General & Admin | 7,663 | 8,003 | 8,484 | 8,062 | 7,955 | 6,396 | Upgrade
|
| Research & Development | 721.34 | 763.77 | 782.14 | 819.45 | 874.72 | 611.93 | Upgrade
|
| Other Operating Expenses | 234.46 | 175.29 | 6.38 | -182.76 | 294.43 | 257.59 | Upgrade
|
| Operating Expenses | 8,701 | 9,001 | 9,346 | 8,753 | 9,219 | 7,365 | Upgrade
|
| Operating Income | 3,305 | 3,474 | 4,796 | 4,487 | 3,970 | 3,026 | Upgrade
|
| Interest Expense | -413.33 | -418.15 | -446.19 | -434.41 | -417.83 | -363.34 | Upgrade
|
| Interest & Investment Income | 647.26 | 698.33 | 751.18 | 1,048 | 757.45 | 718.04 | Upgrade
|
| Currency Exchange Gain (Loss) | -3.15 | -3.15 | 3.32 | -11.12 | 8.67 | 2.1 | Upgrade
|
| Other Non Operating Income (Expenses) | -18.8 | -25.74 | -45.01 | -41.12 | -94.44 | -66.85 | Upgrade
|
| EBT Excluding Unusual Items | 3,517 | 3,725 | 5,060 | 5,048 | 4,224 | 3,316 | Upgrade
|
| Gain (Loss) on Sale of Investments | -378.85 | -361.01 | 38.64 | -3.59 | 196.88 | -16.14 | Upgrade
|
| Gain (Loss) on Sale of Assets | 11.24 | 11.12 | 12.03 | 0.69 | 0.69 | 2.95 | Upgrade
|
| Asset Writedown | 2.14 | -2.93 | 0.42 | -7.06 | -3.08 | -2.89 | Upgrade
|
| Legal Settlements | - | - | - | - | -24.82 | -12.02 | Upgrade
|
| Other Unusual Items | 235.17 | 235.17 | -0.36 | 4.76 | 329.44 | 450.86 | Upgrade
|
| Pretax Income | 3,386 | 3,608 | 5,110 | 5,043 | 4,723 | 3,739 | Upgrade
|
| Income Tax Expense | 559.77 | 606.85 | 851.17 | 789.87 | 754.09 | 647.45 | Upgrade
|
| Earnings From Continuing Operations | 2,826 | 3,001 | 4,259 | 4,253 | 3,969 | 3,092 | Upgrade
|
| Minority Interest in Earnings | -127.76 | -165.24 | -203.65 | -286.85 | -249.11 | -176.38 | Upgrade
|
| Net Income | 2,699 | 2,835 | 4,056 | 3,967 | 3,720 | 2,915 | Upgrade
|
| Net Income to Common | 2,699 | 2,835 | 4,056 | 3,967 | 3,720 | 2,915 | Upgrade
|
| Net Income Growth | -34.26% | -30.09% | 2.25% | 6.63% | 27.60% | -8.58% | Upgrade
|
| Shares Outstanding (Basic) | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 | Upgrade
|
| Shares Outstanding (Diluted) | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 | Upgrade
|
| Shares Change (YoY) | 0.01% | 0.02% | -0.02% | - | - | - | Upgrade
|
| EPS (Basic) | 1.66 | 1.74 | 2.50 | 2.44 | 2.29 | 1.79 | Upgrade
|
| EPS (Diluted) | 1.66 | 1.74 | 2.50 | 2.44 | 2.29 | 1.79 | Upgrade
|
| EPS Growth | -34.27% | -30.10% | 2.27% | 6.63% | 27.61% | -8.57% | Upgrade
|
| Free Cash Flow | 1,647 | 2,314 | 2,475 | 5,615 | 4,419 | -291.32 | Upgrade
|
| Free Cash Flow Per Share | 1.01 | 1.42 | 1.52 | 3.45 | 2.72 | -0.18 | Upgrade
|
| Dividend Per Share | 0.800 | 0.800 | 0.749 | 0.732 | 0.687 | 0.538 | Upgrade
|
| Dividend Growth | 6.81% | 6.81% | 2.32% | 6.55% | 27.69% | -8.66% | Upgrade
|
| Gross Margin | 16.11% | 16.63% | 18.73% | 18.70% | 19.11% | 16.85% | Upgrade
|
| Operating Margin | 4.43% | 4.63% | 6.35% | 6.34% | 5.75% | 4.91% | Upgrade
|
| Profit Margin | 3.62% | 3.78% | 5.37% | 5.60% | 5.39% | 4.73% | Upgrade
|
| Free Cash Flow Margin | 2.21% | 3.09% | 3.28% | 7.93% | 6.40% | -0.47% | Upgrade
|
| EBITDA | 3,881 | 4,068 | 5,462 | 5,002 | 4,390 | 3,415 | Upgrade
|
| EBITDA Margin | 5.21% | 5.42% | 7.23% | 7.07% | 6.36% | 5.54% | Upgrade
|
| D&A For EBITDA | 576.61 | 594.35 | 665.32 | 514.44 | 419.91 | 388.93 | Upgrade
|
| EBIT | 3,305 | 3,474 | 4,796 | 4,487 | 3,970 | 3,026 | Upgrade
|
| EBIT Margin | 4.43% | 4.63% | 6.35% | 6.34% | 5.75% | 4.91% | Upgrade
|
| Effective Tax Rate | 16.53% | 16.82% | 16.66% | 15.66% | 15.97% | 17.32% | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 61,674 | Upgrade
|
| Advertising Expenses | - | 930.48 | 1,082 | 960.69 | 1,054 | 690.74 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.